NICOTINE IMMUNONANOTHERAPEUTICS
    7.
    发明公开
    NICOTINE IMMUNONANOTHERAPEUTICS 有权
    NICOTINE免疫疗法

    公开(公告)号:EP2346528A1

    公开(公告)日:2011-07-27

    申请号:EP09740581.5

    申请日:2009-10-09

    IPC分类号: A61K39/00

    CPC分类号: A61K39/00

    摘要: The present invention provides compositions and systems for delivery of nanocarriers to cells of the immune system. The invention provides nanocarriers capable of stimulating an immune response in T cells and/or in B cells. The invention provides nanocarriers that comprise an immunofeature surface having a plurality of nicotine moieties. The invention provides pharmaceutical compositions comprising nanocarriers. The present invention provides methods of designing, manufacturing, and using nanocarriers and pharmaceutical compositions thereof. For example, the present invention describes nanocarriers capable of eliciting an immune response and the production of anti-nicotine antibodies.

    摘要翻译: 本发明提供了用于将纳米载体递送至免疫系统的细胞的组合物和系统。 本发明提供了能够刺激T细胞和/或B细胞中的免疫应答的纳米载体。 本发明提供了包含具有多个尼古丁部分的免疫特征表面的纳米载体。 本发明提供了包含纳米载体的药物组合物。 本发明提供设计,制造和使用其纳米载体及其药物组合物的方法。 例如,本发明描述了能够引发免疫应答和产生抗尼古丁抗体的纳米载体。